Susquehanna International Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-365,300
| Closed | -$351K | – | 13443 |
|
|
2023
Q2 | $351K | Buy |
365,300
+72,800
| +25% | +$71.9K | ﹤0.01% | 9125 |
|
|
2023
Q1 | $219K | Buy |
292,500
+101,800
| +53% | +$74.3K | ﹤0.01% | 10401 |
|
|
2022
Q4 | $70.6K | Sell |
190,700
-73,000
| -28% | -$30.8K | ﹤0.01% | 11213 |
|
|
2022
Q3 | $113K | Buy |
263,700
+58,300
| +28% | +$57.3K | ﹤0.01% | 11586 |
|
|
2022
Q2 | $160K | Buy |
205,400
+73,700
| +56% | +$65K | ﹤0.01% | 10948 |
|
|
2022
Q1 | $170K | Buy |
+131,700
| New | +$121K | ﹤0.01% | 11435 |
|
|
2021
Q4 | – | Sell |
-95,600
| Closed | -$208K | – | 14205 |
|
|
2021
Q3 | $208K | Buy |
+95,600
| New | +$261K | ﹤0.01% | 11412 |
|
|
2021
Q2 | – | Sell |
-15,700
| Closed | -$51K | – | 13493 |
|
|
2021
Q1 | $51K | Buy |
+15,700
| New | +$56.3K | ﹤0.01% | 12027 |
|
|
2020
Q1 | – | Sell |
-280,800
| Closed | -$1.02M | – | 11097 |
|
|
2019
Q4 | $1.02M | Buy |
280,800
+189,900
| +209% | +$1.53M | ﹤0.01% | 5478 |
|
|
2019
Q3 | $754K | Buy |
90,900
+65,200
| +254% | +$527K | ﹤0.01% | 6343 |
|
|
2019
Q2 | $221K | Sell |
25,700
-7,300
| -22% | -$65.3K | ﹤0.01% | 8936 |
|
|
2019
Q1 | $353K | Buy |
33,000
+10,900
| +49% | +$117K | ﹤0.01% | 6931 |
|
|
2018
Q4 | $193K | Sell |
22,100
-174,100
| -89% | -$2.22M | ﹤0.01% | 7787 |
|
|
2018
Q3 | $3.3M | Sell |
196,200
-79,500
| -29% | -$1.72M | ﹤0.01% | 3228 |
|
|
2018
Q2 | $5.78M | Buy |
275,700
+107,700
| +64% | +$2M | ﹤0.01% | 2536 |
|
|
2018
Q1 | $2.7M | Buy |
168,000
+116,600
| +227% | +$2.31M | ﹤0.01% | 3415 |
|
|
2017
Q4 | $974K | Sell |
51,400
-93,400
| -65% | -$1.69M | ﹤0.01% | 5291 |
|
|
2017
Q3 | $2.04M | Buy |
144,800
+105,800
| +271% | +$957K | ﹤0.01% | 3871 |
|
|
2017
Q2 | $291K | Sell |
39,000
-24,200
| -38% | -$158K | ﹤0.01% | 7642 |
|
|
2017
Q1 | $411K | Buy |
63,200
+46,200
| +272% | +$258K | ﹤0.01% | 6846 |
|
|
2016
Q4 | $75K | Sell |
17,000
-9,900
| -37% | -$41.5K | ﹤0.01% | 9189 |
|
|
2016
Q3 | $126K | Sell |
26,900
-19,700
| -42% | -$117K | ﹤0.01% | 7851 |
|
|
2016
Q2 | $306K | Buy |
46,600
+20,400
| +78% | +$144K | ﹤0.01% | 6923 |
|
|
2016
Q1 | $167K | Buy |
+26,200
| New | +$134K | ﹤0.01% | 8124 |
|
|
2015
Q4 | – | Sell |
-11,800
| Closed | -$71K | – | 10128 |
|
|
2015
Q3 | $71K | Sell |
11,800
-17,000
| -59% | -$118K | ﹤0.01% | 9277 |
|
|
2015
Q2 | $197K | Sell |
28,800
-17,900
| -38% | -$114K | ﹤0.01% | 9303 |
|
|
2015
Q1 | $283K | Buy |
46,700
+31,800
| +213% | +$212K | ﹤0.01% | 8073 |
|
|
2014
Q4 | $103K | Sell |
14,900
-43,700
| -75% | -$321K | ﹤0.01% | 9176 |
|
|
2014
Q3 | $477K | Buy |
58,600
+7,300
| +14% | +$57.1K | ﹤0.01% | 7297 |
|
|
2014
Q2 | $417K | Sell |
51,300
-34,700
| -40% | -$263K | ﹤0.01% | 7822 |
|
|
2014
Q1 | $674K | Sell |
86,000
-35,700
| -29% | -$302K | ﹤0.01% | 6220 |
|
|
2013
Q4 | $1.08M | Sell |
121,700
-84,000
| -41% | -$750K | ﹤0.01% | 5381 |
|
|
2013
Q3 | $1.73M | Buy |
205,700
+46,900
| +30% | +$380K | ﹤0.01% | 4355 |
|
|
2013
Q2 | $1.19M | Buy |
+158,800
| New | +$1.22M | ﹤0.01% | 4708 |
|
Susquehanna International Group's SPPI Position: Q3 2023 in Review
Susquehanna International Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 243,555 shares — an estimated $234K sold.
Susquehanna International Group first reported a position in SPPI in Q2 2013 and held it in 35 quarters. The position peaked at $2.61M in Q4 2013. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Susquehanna International Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 243,555 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $234K.
- Susquehanna International Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Susquehanna International Group's Spectrum Pharmaceuticals Inc position peaked at $2.61M in Q4 2013.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.